Off-brand copies of the GLP-1 drugs were used during a shortage of Zepbound and Mounjaro. REUTERS The FDA permits compounded versions of brand name drugs when they are in shortage, and the shift ...

FDA advises that additional “ methods to mitigate bias may be helpful, such as cross-validation, bootstrapping, bagging, ensembling, and the use of synthetic or augmented data” (emphasis added).